ORAL LEVONANTRADOL IN THE TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS - PRELIMINARY-OBSERVATIONS

被引:21
作者
DIASIO, RB
ETTINGER, DS
SATTERWHITE, BE
机构
[1] MED COLL VIRGINIA,DEPT PHARMACOL,RICHMOND,VA 23298
[2] JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205
关键词
D O I
10.1002/j.1552-4604.1981.tb02579.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S81 / S85
页数:5
相关论文
共 9 条
[1]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].
CHANG, AE ;
SHILING, DJ ;
STILLMAN, RC ;
GOLDBERG, NH ;
SEIPP, CA ;
BAROFSKY, I ;
SIMON, RM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824
[2]   IS THC AN EFFECTIVE ANTI-EMETIC FOR CANCER-PATIENTS - OPINION 1 [J].
FRYTAK, S .
CA-A CANCER JOURNAL FOR CLINICIANS, 1980, 30 (05) :278-282
[3]   SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTI-EMETIC IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].
HERMAN, TS ;
EINHORN, LH ;
JONES, SE ;
NAGY, C ;
CHESTER, AB ;
DEAN, JC ;
FURNAS, B ;
WILLIAMS, SD ;
LEIGH, SA ;
DORR, RT ;
MOON, TE .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (23) :1295-1297
[4]   DELTA-9-TETRAHYDROCANNABINOL FOR REFRACTORY VOMITING INDUCED BY CANCER-CHEMOTHERAPY [J].
LUCAS, VS ;
LASZLO, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (12) :1241-1243
[5]   ANTI-EMETIC ACTIVITY OF N-METHYLLEVONANTRADOL AND NABILONE IN CISPLATIN-TREATED CATS [J].
MCCARTHY, LE ;
BORISON, HL .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S30-S37
[6]   ANTI-EMETICS IN PATIENTS RECEIVING CHEMOTHERAPY FOR CANCER - RANDOMIZED COMPARISON OF DELTA-9-TETRAHYDROCANNABINOL AND PROCHLORPERAZINE [J].
SALLAN, SE ;
CRONIN, C ;
ZELEN, M ;
ZINBERG, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (03) :135-138
[7]   ANTIEMETIC EFFECT OF DELTA-9-TETRAHYDROCANNABINOL IN PATIENTS RECEIVING CANCER CHEMOTHERAPY [J].
SALLAN, SE ;
ZINBERG, NE ;
FREI, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (16) :795-797
[8]   PHARMACOKINETICS OF LEVONANTRADOL IN LABORATORY-ANIMALS AND MAN [J].
SHEPARD, RM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S190-S200
[9]  
1978, MED LETT, V20, P81